Immune dysfunction in patients with chronic lymphocytic leukemia and challenges during COVID-19 pandemic
P Langerbeins, B Eichhorst - Acta haematologica, 2021 - karger.com
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
[HTML][HTML] Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
P Langerbeins, B Eichhorst - Acta Haematologica - ncbi.nlm.nih.gov
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
P Langerbeins, B Eichhorst - Acta Haematologica, 2021 - karger.com
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
P Langerbeins, B Eichhorst - Acta Haematol., 2021 - kups.ub.uni-koeln.de
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
P Langerbeins, B Eichhorst - Acta Haematologica, 2021 - search.ebscohost.com
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
P Langerbeins, B Eichhorst - Acta haematologica, 2021 - pubmed.ncbi.nlm.nih.gov
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
P Langerbeins, B Eichhorst - Acta Haematologica, 2021 - europepmc.org
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
P Langerbeins, B Eichhorst - Acta haematologica, 2021 - pubmed.ncbi.nlm.nih.gov
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
P Langerbeins, B Eichhorst - Acta Haematol., 2021 - kups.ub.uni-koeln.de
The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been first
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …
described in December 2019 in Wuhan, China, and has led to a worldwide pandemic ever …